Frequently Asked Questions
OGXI
Delaware
Our transfer agent is Computershare. They can be contacted at: Computershare 350 Indiana Street Suite 800 Golden, CO. 80401 Phone: 1-818-502-1404 http://www.computershare.com
Our transfer agent, Computershare, will perform any necessary replacements. A fee is associated with this service.
If you own shares through a brokerage firm, you need to contact that firm directly to change your account address.
No, we do not currently have a program in place for the purchase of shares directly from the company.
Shares of OncoGenex Pharmaceuticals, Inc. common stock can be purchased by contacting a securities broker. We are traded on Nasdaq under the symbol OGXI.
Our CUSIP number is 68230A 106
Ernst & Young LLP
Please submit your question using the form below. * Required fields
About OncoGeneX
For Patients
For Physicians
For Investors
Careers With Us
Investors
SHAREHOLDER TOOLS

© 2004-2011 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.
About OncoGenex
OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
For Patients
OncoGenex is uniquely focused on the challenge of cancer treatment resistance. We currently have several on-going clinical trials that may be of interest to you.
For Physicians
OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.




show all
hide all